Stimuli-responsive nanoplatforms for central nervous system disorders: integrating delivery, modulation, and imaging | Synapse
May 7, 2026
Stimuli-responsive nanoplatforms for central nervous system disorders: integrating delivery, modulation, and imaging
Key Points
The research aims to explore the effectiveness of stimuli-responsive nanoplatforms in treating central nervous system disorders by facilitating drug delivery and neuromodulation.
Integration of endogenous cues and external fields for BBB-crossing delivery.
Application of nanoplatforms for imaging-guided therapies.
Assessment of neuromodulation capabilities in adaptive treatment strategies.
Demonstrated successful crossing of the blood-brain barrier by nanoplatforms.
Showed enhanced neuromodulation effects in targeted CNS regions.
Improved imaging accuracy leading to more effective therapy guidance.
Abstract
Stimuli-responsive nanoplatforms integrate endogenous cues and external fields to enable BBB-crossing delivery, neuromodulation and imaging-guided therapy, advancing adaptive treatment for CNS disorders.